경카테터 대동맥판 치환술 시장 : 시술별, 디바이스별, 최종사용자별, 지역별

Transcatheter Aortic Valve Replacement Market is estimated to be valued at USD 8.12 Bn in 2026 and is expected to reach USD 13.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.

The transcatheter aortic valve replacement (TAVR) market is expanding rapidly as healthcare providers adopt this minimally invasive alternative to traditional open-heart surgery for treating aortic valve stenosis. Physicians increasingly recommend TAVR for patients at high or intermediate surgical risk because it reduces recovery times, lowers complication rates, and improves quality of life. Rising rates of cardiovascular diseases, along with an aging population, are driving demand for innovative, less invasive cardiac interventions.

Medical technology advancements, including next-generation valves and enhanced delivery systems, are strengthening market growth by improving procedural safety and effectiveness. Device manufacturers and healthcare providers are actively working to increase accessibility and optimize patient outcomes through continuous innovation and professional training. Growing awareness of early diagnosis, combined with wider adoption of minimally invasive procedures, is creating a dynamic market that emphasizes patient-centered care and expands treatment options for aortic valve disease worldwide.

Market Dynamics

The TAVR market grows primarily due to the rising prevalence of aortic valve stenosis and the increasing preference for minimally invasive procedures over traditional open-heart surgery. Aging populations and the global rise in cardiovascular diseases are creating strong demand for effective, less invasive treatment options. Patients and healthcare providers are actively seeking solutions that shorten recovery times, reduce complication risks, and improve long-term outcomes, making TAVR the preferred choice for high- and intermediate-risk patients.

Technological innovations are actively transforming the market. Manufacturers are launching next-generation transcatheter valves, advanced delivery systems, and improved imaging techniques that enhance procedural accuracy, safety, and effectiveness. These innovations allow physicians to treat a broader range of patients, including those with complex anatomies, expanding the potential patient base. Healthcare facilities are also adopting professional training programs and upgrading infrastructure to support higher adoption rates and improve procedural efficiency.

Despite its rapid growth, the TAVR market faces challenges such as high procedural costs, reimbursement limitations in some regions, and restricted access in emerging markets. Patient-specific factors, including comorbidities and anatomical constraints, require careful planning and tailored treatment approaches. Nevertheless, rising awareness of early diagnosis, ongoing clinical research, and a focus on patient-centered innovations continue to propel market growth, creating a dynamic environment that advances TAVR as a safe and effective treatment for aortic valve disease worldwide.

Key Features of the Study

• This report provides in-depth analysis of the Transcatheter Aortic Valve Replacement Market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Transcatheter Aortic Valve Replacement Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Edwards Lifesciences Corp., Medtronic Plc., Abbott Laboratories., Boston Scientific Corp., MicroPort Scientific Corp., JenaValve Technology GmbH., Cardiovascular Systems, Inc., Symetis SA., Lepu Medical Technology Co., Ltd., Terumo Corporation., St. Jude Medical (now part of Abbott)., AtriCure, Inc., Vascular Solutions, Inc., Biotronik SE & Co. KG., and Cook Medical
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Transcatheter Aortic Valve Replacement Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Transcatheter Aortic Valve Replacement Market

Market Segmentation

• By Procedure Type Insights
  • Transfemoral
  • Transapical
  • Other Approaches
• By Device Type Insights
  • Balloon-Expandable Valves
  • Self-Expanding Valves
• By End User Insights
  • Hospitals
  • Ambulatory Surgical Centers
  • Independent Cardiac Catheterization Labs
  • Others
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Edwards Lifesciences Corp.
  • Medtronic Plc.
  • Abbott Laboratories.
  • Boston Scientific Corp.
  • MicroPort Scientific Corp.
  • JenaValve Technology GmbH.
  • Cardiovascular Systems, Inc.
  • Symetis SA.
  • Lepu Medical Technology Co., Ltd.
  • Terumo Corporation.
  • Jude Medical (now part of Abbott).
  • AtriCure, Inc.
  • Vascular Solutions, Inc.
  • Biotronik SE & Co. KG.
  • Cook Medical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Procedure Type
  • Market Snippet, By Device Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • PEST Analysis
  • PORTER's Five Forces Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Transcatheter Aortic Valve Replacement Market, By Procedure Type, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Transfemoral
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Transapical
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Other Approaches
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Transcatheter Aortic Valve Replacement Market, By Device Type, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Balloon-Expandable Valves
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Self-Expanding Valves
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Transcatheter Aortic Valve Replacement Market, By End User, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Ambulatory Surgical Centers
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Independent Cardiac Catheterization Labs
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Others
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

7. Global Transcatheter Aortic Valve Replacement Market, By Region, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
  • Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
  • Edwards Lifesciences Corp.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Medtronic Plc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Abbott Laboratories
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Boston Scientific Corp.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • MicroPort Scientific Corp.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • JenaValve Technology GmbH
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Cardiovascular Systems, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Symetis SA.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Lepu Medical Technology Co., Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Terumo Corporation.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • St. Jude Medical
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • AtriCure, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Vascular Solutions, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Biotronik SE & Co. KG.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Cook Medical
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates

9. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Section

• References
• Research Methodology
• About Us and Sales Contact